In mice, obese dads produce heavier daughters with epigenetically altered breast tissue

April 4, 2014

Obese male mice and normal weight female mice produce female pups that are overweight at birth and in childhood, and have increased number of "terminal end buds" in their breast tissue—the site where cancer often develops in rodents.

The findings, presented by a Georgetown Lombardi Comprehensive Cancer Center researcher at the AACR Annual Meeting 2014, come from one of the first animal studies to examine the impact of paternal obesity on future generations' cancer risk.

In addition, the researchers say they've found evidence that obesity could change the microRNA (miRNA) signature—epigenetic regulators of gene expression—in both the dad's sperm and the daughter's , suggesting that miRNAs may carry the epigenetic information from obese dads to their daughters.

The miRNAs identified are known to regulate insulin receptor signaling, which is linked to alterations in , and others molecular pathways that are associated with development such as estrogen receptor signaling.

Obesity seems to sometimes run in families, as does some breast cancers. Maternal obesity is believed to influence both conditions in humans—a woman who is heavy in pregnancy can produce larger babies, who may have increased risk of breast cancer later in life. But few if any studies have looked at the influence of dad's obesity on his offspring's cancer risk.

"This study provides evidence that, in animals, a fathers' body weight at the time of conception affects both their daughters' body weight both at birth and in childhood and likely their risk of breast cancer later in life," says the study's lead investigator, Sonia de Assis, PhD, an assistant professor in the Department of Oncology at Georgetown Lombardi. "Of course our study was done in mice, but it would be very interesting to know if the same associations hold for daughters of human fathers who were obese at the time of conception," she says.

De Assis and colleagues have previously found that pregnant rats that ate a increased in their female daughters and "granddaughters." That same risk was passed down from the son of the high-fat fed mother to the son's daughter.

"Researchers traditionally study the maternal link to weight and . This unusual study demonstrates a potential paternal link as well," de Assis says. "Until we know about this association in men, we should stick to what we all know is good advice: women—and men—should eat a balanced diet not only for their own benefit but also to give their offspring's the best chances of being healthy."

Explore further: Pregnant rats exposed to obesity hormone lose birth's protective effect on breast cancer

Related Stories

Pregnant rats exposed to obesity hormone lose birth's protective effect on breast cancer

October 29, 2013
Like humans, young rats that give birth have a reduced risk of breast cancer later in life. But a new study shows that this protective effect in animals is negated if they're exposed to an obesity-linked hormone during pregnancy.

Fathers' diet, bodyweight and health at conception may contribute to obesity in offspring

January 16, 2014
Research involving rats suggests that there is a biological link between paternal diet, bodyweight and health at the time of conception and the health of his offspring. In a new research report published online in The FASEB ...

Breast cancer risks acquired in pregnancy may pass to next three generations

September 11, 2012
Chemicals or foods that raise estrogen levels during pregnancy may increase cancer risk in daughters, granddaughters, and even great-granddaughters, according to scientists from Virginia Tech and Georgetown University.

Obese dads pass on predisposition to obesity and metabolic disorders to their kids

July 11, 2013
If you are obese and hope to be a father, here's another reason to lose weight: your children and grandchildren may inherit your waistline or metabolic disorders. That's because scientists have discovered in mice that obese ...

Excess estrogen in pregnancy can silence BRCA1 in daughters, increasing breast cancer risk

April 9, 2013
Excess estrogen levels during pregnancy can disable, in their daughters, a powerful breast cancer tumor suppressor gene, say researchers at Georgetown Lombardi Comprehensive Cancer Center. They found the DNA repair gene BRCA1 ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.